Rocket Pharmaceuticals Inc’s recent filing unveils that its CEO Shah Gaurav acquired Company’s shares for reported $0.1 million on Apr 10 ’25. In the deal valued at $5.08 per share,20,000 shares were bought. As a result of this transaction, Shah Gaurav now holds 792,680 shares worth roughly $5.18 million.
Then, Patel Kinnari bought 21,099 shares, generating $99,165 in total proceeds. Upon buying the shares at $4.70, the insider now owns 26,774 shares.
Before that, White Mark Andrew bought 3,382 shares. Rocket Pharmaceuticals Inc shares valued at $15,777 were divested by the Former Officer at a price of $4.67 per share.
BMO Capital Markets initiated its Rocket Pharmaceuticals Inc [RCKT] rating to an Outperform in a research note published on March 12, 2025; the price target was $50. A number of analysts have revised their coverage, including Wedbush’s analysts, who began to cover the stock in late December with a ‘”an Outperform”‘ rating. Jefferies began covering RCKT with “Buy” recommendation on December 18, 2024. Scotiabank started covering the stock on October 16, 2024. It rated RCKT as “a Sector outperform”.
Price Performance Review of RCKT
On Tuesday, Rocket Pharmaceuticals Inc [NASDAQ:RCKT] saw its stock jump 10.49% to $6.53. Over the last five days, the stock has gained 36.33%. Rocket Pharmaceuticals Inc shares have fallen nearly -48.05% since the year began. Nevertheless, the stocks have fallen -73.01% over the past one year. While a 52-week high of $26.98 was reached on 01/02/25, a 52-week low of $4.55 was recorded on 04/09/25. SMA at 50 days reached $8.44, while 200 days put it at $14.75.
Levels Of Support And Resistance For RCKT Stock
The 24-hour chart illustrates a support level at 6.04, which if violated will result in even more drops to 5.54. On the upside, there is a resistance level at 6.90. A further resistance level may holdings at 7.26. The Relative Strength Index (RSI) on the 14-day chart is 46.49, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -0.02, which suggests price will go down in the next trading period. Percent R suggests that price movement has been low at 42.27%. Stochastics %K at 37.26% indicates the stock is a holding.
How much short interest is there in Rocket Pharmaceuticals Inc?
A steep rise in short interest was recorded in Rocket Pharmaceuticals Inc stocks on 2025-03-31, growing by 1.4 million shares to a total of 12.44 million shares. Yahoo Finance data shows the prior-month short interest on 2025-02-28 was 11.04 million shares. There was a rise of 11.28%, which implies that there is a positive sentiment for the stock.
The most recent change occurred on April 02, 2024 when Goldman began covering the stock and recommended ‘”a Neutral”‘ rating along with a $39 price target.
